Skip to main content
. Author manuscript; available in PMC: 2018 May 3.
Published in final edited form as: Cell Rep. 2018 Apr 17;23(3):823–837. doi: 10.1016/j.celrep.2018.03.078

Figure 7. ZRANB1 Levels Correlate with EZH2 Levels and Poor Survival in Human Breast Cancer.

Figure 7

(A) Immunohistochemical staining of ZRANB1 and EZH2 in representative breast tumor specimens. Scale bar, 50 μm.

(B) Correlation between ZRANB1 and EZH2 protein levels in human breast tumors. The p value was calculated from a chi-square test. R is the Spearman correlation coefficient.

(C) ZRANB1 protein scores (x axis) in primary breast tumors positively correlate with EZH2 protein scores (y axis) in individual patients. The p value was calculated from a linear regression analysis. R is the correlation coefficient. Protein score = the percentage of immunopositive cells × immunostaining intensity.

(D) Kaplan-Meier curves of overall survival of breast cancer patients (n = 138 patients), stratified by ZRANB1 protein levels. Protein score = the percentage of immunopositive cells × immunostaining intensity. High or low protein expression was defined using the mean score of all samples as a cutoff point. The p value was calculated from a log rank test. HR, hazard ratio.

See also Figure S7.